HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.

Abstract
Protein tyrosine phosphatases that act in different cellular pathways are described most commonly as tumor suppressors, but also as oncogenes. Their role has previously been described in colorectal cancer, as well as in gastric, breast, thyroid, prostate, ovarian, pancreatic, glioma, liver, leukemia and many other cancers. In a previous study, we have described protein tyrosine phosphatase receptor type T, M, Z1 and Q genes (PTPRT, PTPRM, PTPRZ1 and PTPRQ) hypermethylated in sporadic colorectal cancer. Thus, in this study, we examined the relation of unbalanced chromosomal alterations within regions covering these four protein tyrosine phosphatase genes with this cancer. One hundred and two cancer tissues were molecularly characterized, including analysis of the BRAF and K-ras mutations and methylator phenotype. The analysis of chromosomal aberrations was performed using Comparative Genomic Hybridization. We observed amplification of three regions containing genes coding for PTPs, such as PTPRZ1 (7q31.3, amplified in 23.5% of cases), PTPRQ (12q21.2, amplified in 5.9% of cases), PTPRT (20q12, amplified in 29.4% of cases), along with deletions in the region of PTPRM (18p11.2, deleted in 21.6% of cases). These data may suggest that in sporadic colorectal cancer PTPRZ1, PTPRT, PTPRQ probably act as oncogenes, while PTPRM acts as a tumor suppressor gene. Our study also revealed that gains on chromosome 20q12 and losses on chromosome 18p11.2 are connected with the absence of the BRAF mutation and the conventional adenocarcinoma pathway.
AuthorsIzabela Laczmanska, Pawel Karpinski, Joanna Kozlowska, Marek Bebenek, David Ramsey, Tomasz Sedziak, Piotr Ziolkowski, Maria M Sasiadek
JournalPathology, research and practice (Pathol Res Pract) Vol. 210 Issue 12 Pg. 893-6 (Dec 2014) ISSN: 1618-0631 [Electronic] Germany
PMID25169130 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier GmbH. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • PTPRM protein, human
  • PTPRQ protein, human
  • PTPRT protein, human
  • PTPRZ1 protein, human
  • Receptor-Like Protein Tyrosine Phosphatases
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
Topics
  • Adenocarcinoma (enzymology, genetics, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics)
  • Chromosomes, Human, Pair 18
  • Chromosomes, Human, Pair 20
  • Colorectal Neoplasms (enzymology, genetics, pathology)
  • Comparative Genomic Hybridization
  • DNA Copy Number Variations
  • DNA Mutational Analysis
  • Female
  • Gene Dosage
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Phenotype
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins B-raf (genetics)
  • Proto-Oncogene Proteins p21(ras)
  • Receptor-Like Protein Tyrosine Phosphatases (genetics)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 2 (genetics)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 (genetics)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5 (genetics)
  • ras Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: